allylamine has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Qian, C; St Peter, WL; Ye, X | 1 |
| Andersson, M; Elgen, K; Hagman, A; Larsson, L; Leward, S; Wolff, T | 1 |
1 trial(s) available for allylamine and Cardiovascular Stroke
| Article | Year |
|---|---|
Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine.
Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Meperidine; Middle Aged; Morphine; Myocardial Infarction; Parasympatholytics | 1988 |
1 other study(ies) available for allylamine and Cardiovascular Stroke
| Article | Year |
|---|---|
Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
Topics: Age Factors; Aged; Allylamine; Anticholesteremic Agents; Cohort Studies; Colesevelam Hydrochloride; Databases, Factual; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hyperlipidemias; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Stroke; Treatment Outcome | 2013 |